Oxandrolone induces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty.
We describe the treatment of 3 boys, mean age 14.9 years (range 13.8-16.1 years) with constitutional delay of growth and puberty using oxandrolone in two dose regimens, 2.5 or 1.25 mg/day for 3 months. Treatment induced an increase in mean height velocity from 5.1 to 8.5 cm/year; this was sustained at 8.8 cm/year in the period following treatment. Growth hormone (GH), luteinising hormone and testosterone secretion were assessed by overnight or 24-hour venous sampling at 15-min intervals before, during treatment and after cessation of treatment. A computer programme was used to analyse GH secretory dynamics. The 3 boys had a mean sustained increase in total GH secretion of 190%. The increase in GH secretion was associated with an increase in amplitude of GH pulses rather than an alteration in pulse frequency.
Stanhope
R
R
Endocrine Unit, Middlesex Hospital, London, UK.
Hindmarsh
P
P
Pringle
P J
PJ
Holownia
P
P
Honour
J
J
Brook
C G
CG
D000293:Adolescent; D001824:Body Constitution; D006130:Growth Disorders / Q000188:drug therapy* / Q000503:physiopathology; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D010074:Oxandrolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011628:Puberty, Delayed / Q000188:drug therapy* / Q000503:physiopathology; D013739:Testosterone / Q000378:metabolism
D013739:Testosterone; D010074:Oxandrolone; D007986:Luteinizing Hormone; D013006:Growth Hormone